Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China · Delayed Price · Currency is CNY 16.40
-0.26 (-1.56%)
Feb 4, 2026, 3:00 PM CST
SHA:603108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -157.84 | 55.28 | 273.3 | 417.75 | 380.23 | 329.98 |
Depreciation & Amortization | 373.05 | 373.05 | 375.02 | 384.18 | 365.2 | 302.65 |
Other Amortization | 49.01 | 49.01 | 26.31 | 30.84 | 25.11 | 20.8 |
Loss (Gain) From Sale of Assets | -11.46 | -11.46 | -11.77 | -6.18 | -1.73 | -5.68 |
Asset Writedown & Restructuring Costs | 34.11 | 34.11 | 24.53 | 38.22 | 3.08 | 1.36 |
Loss (Gain) From Sale of Investments | -109.82 | -109.82 | -232 | -137.05 | -130.72 | -136.27 |
Provision & Write-off of Bad Debts | 81.71 | 81.71 | 88.9 | 198.37 | 51.91 | 59.38 |
Other Operating Activities | 902.85 | 459.28 | 518.77 | 571.48 | 507.49 | 422.99 |
Change in Accounts Receivable | -115.07 | -115.07 | 357.35 | -2,350 | -668.83 | -534.9 |
Change in Inventory | -72.59 | -72.59 | 93.37 | -157.62 | -360.17 | -12.18 |
Change in Accounts Payable | -66.98 | -66.98 | -781.88 | 665.31 | 206.87 | -99.79 |
Operating Cash Flow | 877.4 | 646.95 | 729.72 | -428.86 | 371.11 | 323.44 |
Operating Cash Flow Growth | 16.41% | -11.34% | - | - | 14.74% | 31.12% |
Capital Expenditures | -199.31 | -229.16 | -319.88 | -272.12 | -301.09 | -331.94 |
Sale of Property, Plant & Equipment | 14.43 | 7.96 | 22.86 | 20.84 | 16.44 | 14.39 |
Cash Acquisitions | - | -0.18 | -122.28 | -18.93 | -154.45 | -417.95 |
Divestitures | - | - | 99.25 | - | - | - |
Investment in Securities | -275 | -198.08 | -5.13 | -94.01 | -1.38 | -306.25 |
Other Investing Activities | 68.16 | -39.72 | 71.6 | 37.32 | 24.9 | 28.99 |
Investing Cash Flow | -393.2 | -460.67 | -227.34 | -322.57 | -415.08 | -1,013 |
Short-Term Debt Issued | - | 12 | 5 | - | - | - |
Long-Term Debt Issued | - | 9,470 | 10,013 | 8,443 | 6,447 | 5,476 |
Total Debt Issued | 8,202 | 9,482 | 10,018 | 8,443 | 6,447 | 5,476 |
Long-Term Debt Repaid | - | -8,822 | -9,835 | -7,393 | -5,512 | -4,442 |
Net Debt Issued (Repaid) | 51.77 | 659.83 | 182.85 | 1,051 | 935.6 | 1,034 |
Issuance of Common Stock | 10 | 28 | - | - | - | - |
Common Dividends Paid | -283.76 | -337.34 | -377.52 | -244.17 | -272.79 | -225.95 |
Other Financing Activities | -229.87 | -258.19 | -136.64 | -318.35 | -567.86 | -2.53 |
Financing Cash Flow | -451.86 | 92.3 | -331.32 | 488.13 | 94.95 | 805.81 |
Foreign Exchange Rate Adjustments | -2.1 | -2.86 | -0.07 | 0.47 | -1.36 | -0.8 |
Net Cash Flow | 30.25 | 275.72 | 171 | -262.83 | 49.63 | 115.18 |
Free Cash Flow | 678.1 | 417.78 | 409.84 | -700.98 | 70.03 | -8.5 |
Free Cash Flow Growth | 48.87% | 1.94% | - | - | - | - |
Free Cash Flow Margin | 9.16% | 5.03% | 4.48% | -6.68% | 0.79% | -0.12% |
Free Cash Flow Per Share | 1.14 | 0.68 | 0.70 | -1.18 | 0.12 | -0.01 |
Cash Interest Paid | - | - | - | 9.42 | 6.27 | 7.67 |
Cash Income Tax Paid | 381.81 | 548.57 | 546.76 | 509.43 | 488.64 | 406.72 |
Levered Free Cash Flow | 704.18 | 252.85 | 219.42 | -1,062 | -567.62 | -796.25 |
Unlevered Free Cash Flow | 882 | 448.38 | 428.19 | -863.38 | -391.42 | -643.75 |
Change in Working Capital | -284.21 | -284.21 | -333.33 | -1,906 | -843.77 | -672.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.